 | • レポートコード：B-MOR-05397 • 出版社/出版日：Mordor Intelligence / 2018年3月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、幹細胞治療の世界市場について調べ、幹細胞治療の世界規模、市場動向、市場環境、製品別分析、治療適用別分析、治療・技術別分析、バンキングの種類別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・幹細胞治療の世界市場インサイト ・幹細胞治療の世界市場環境 ・幹細胞治療の世界市場動向 ・幹細胞治療の世界市場規模 ・幹細胞治療の世界市場規模：製品別 ・幹細胞治療の世界市場規模：治療適用別 ・幹細胞治療の世界市場規模：治療・技術別 ・幹細胞治療の世界市場規模：バンキングの種類別 ・幹細胞治療の世界市場：地域別市場規模・分析 ・幹細胞治療の北米市場規模・予測 ・幹細胞治療のアメリカ市場規模・予測 ・幹細胞治療のヨーロッパ市場規模・予測 ・幹細胞治療のアジア市場規模・予測 ・幹細胞治療の日本市場規模・予測 ・幹細胞治療の中国市場規模・予測 ・幹細胞治療のインド市場規模・予測 ・幹細胞治療の韓国市場規模・予測 ・関連企業情報・競争状況 |
The Behavioral Rehabilitation Market is expected to witness a CAGR of 13.7% during the forecast period. North America dominates the global market due to the high incidence diseases such as cancer and diabetes which can now be cured by stem cell therapies.
Increased Awareness about Umbilical Stem Cells
Currently, there is an increase in the number of clinical trials for testing future treatment possibilities of cord blood. Over 200 National Institutes of Health (NIH) funded clinical trials with cord blood are currently being conducted in the United States alone. The potential implications of the results are a cause of hope among scientists and healthcare providers. In the United Kingdom, a petition has been submitted to increase the awareness of umbilical cord cells. In United States, CordBloodAwareness.org was created out of a need to increase awareness about the life-saving power of umbilical cord blood stem cells. Thus increasing awareness about umbilical stem cells.
Additionally, increase in the patient population, increase in the approval for clinical trials in stem cell research, growing demand as regenerative treatment option and rising R&D initiatives to develop therapeutic options for chronic disease are also fuelling Stem Cell Therapeutics Market globally.
Ethical and Moral Framework
Stem cells are often viewed as a hope as an alternative form of therapies. However, there has been a strong debate over the use of stem cells in the development of novel therapies. It is a matter of high priority on the political and ethical agenda of many countries. As much as there is a great scope on the therapeutic front, there is an equally strong opposing force on the ethical front. For example, embryonic stem cell research is a morally complex scenario. There are different viewpoints on this issue. Embryos are considered as a Person or as a potential Person. This is one side of the moral issue which is being catered to which is restraining the growth of stem cell therapeutics market.
Additionally, expensive procedures and regulatory complications are also hindering the growth of Stem Cell Therapeutics Market.
North America is dominating the market
One of the largest driving factors for the stem cell market in the US is the high purchasing power of the citizens in the country. There is an increasing incidence diseases such as cancer and diabetes which can now be cures by stem cell therapies. There is also increased awareness about the available stem cell procedures and therapies among people which in turn increases the demand for this market. Thus North America dominates Stem Cell therapeutics Market.
Key Developments in the Market
• February 2018: Astellas Acquires Universal Cells, Inc. to create cell therapy products.
• January 2018: Astellas Completes Acquisition of Mitobridge, Inc.
Major Players: VERICEL CORPORATION, ASTELLAS PHARMA, ATHERSYS, FATE THERAPEUTICS INC., CYTORI THERAPEUTICS, INC., GERON CORPORATION, THERMO FISHER SCIENTIFIC, PLURISTEM THERAPEUTICS INC., VIACYTE, INC., OSIRIS THERAPEUTICS, INC. and CAPRICOR THERAPEUTICS INC. are amongst others.
Reasons to Purchase this Report
• Current and future stem cell therapeutics market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porters Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities And Challenges Analysis (DROC)
6.1 Market Driver
6.1.1 Increased Awareness About Umbilical Stem Cells
6.1.2 Increase in the Patient Population
6.1.3 Increase in the Approval for Clinical Trials in Stem Cell Research
6.1.4 Growing Demand As Regenerative Treatment Option
6.1.5 Rising R&D Initiatives to Develop Therapeutic Options for Chronic Disease
6.2 Market Restraints
6.2.1 Expensive Procedures
6.2.2 Regulatory Complications
6.2.3 Ethical and Moral Framework
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product
7.1.1 Adult Stem Cells
7.1.2 Human Embryonic Cells
7.1.3 Pluripotent Stem Cell
7.1.4 Others
7.2 By Therapeutic Applications
7.2.1 Regenerative Medicine
7.2.2 Neurological Disorders
7.2.3 Orthopaedic Treatments
7.2.4 Oncology Disorders
7.2.5 Diabetes
7.2.6 Injuries & Wounds
7.2.7 Cardiovascular Disorders
7.2.8 Others
7.3 By Treatment Types
7.3.1 Allogeneic Stem Cell Therapy
7.3.2 Auto Logic Stem Cell Therapy
7.3.3 Syngeneic Stem Cell Therapy
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United Kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe
7.4.3 Asia-Pacific
7.4.3.1 China
7.4.3.2 Japan
7.4.3.3 India
7.4.3.4 Australia & New Zealand
7.4.3.5 South Korea
7.4.3.6 Rest of Asia-Pacific
7.4.4 Middle East & Africa
7.4.4.1 GCC
7.4.4.2 South Africa
7.4.4.3 Rest of Middle East & Africa
7.4.5 South America
7.4.5.1 Brazil
7.4.5.2 Argentina
7.4.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches
9. Company Profiles
9.1 Vericel Corporation
9.2 Astellas Pharma
9.3 Athersys
9.4 Fate Therapeutics Inc.
9.5 Cytori Therapeutics, Inc.
9.6 Geron Corporation
9.7 Thermo Fisher Scientific
9.8 Pluristem Therapeutics Inc.
9.9 Viacyte, Inc.
9.10 Osiris Therapeutics, Inc.
9.11 Capricor Therapeutics Inc.
10. Future Outlook of the Market